𝔖 Bobbio Scriptorium
✦   LIBER   ✦

An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region

✍ Scribed by Tatsunori Nakano; Gillian M. G. Lau; Grace M. L. Lau; Masaya Sugiyama; Masashi Mizokami

Book ID
111239663
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
284 KB
Volume
32
Category
Article
ISSN
0106-9543

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

An update on treatment of hepatitis C vi
An update on treatment of hepatitis C virus genotype 1 infection and viral load assessments
✍ Bryan Cobb; Regis A. Vilchez πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 724 KB

According to the recently released American Association for the Study of Liver Diseases (AASLD) guidelines for the treatment of hepatitis C virus (HCV) genotype 1 chronic infection, 1 in treatment-naΔ± Β¨ve subjects the association of boceprevir or telaprevir with peginterferon-alpha and ribavirin is

Analysis of the complete hepatitis B vir
Analysis of the complete hepatitis B virus genome in patients with genotype C chronic hepatitis in relation to HBeAg and anti-HBe
✍ KaiYu Zhang; Fumio Imazeki; Kenichi Fukai; Makoto Arai; Tatsuo Kanda; Rintaro Mi πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 144 KB πŸ‘ 2 views

## Abstract To investigate the relationship between viral factors and the development of chronic hepatitis B, the entire hepatitis B virus (HBV) genome of chronic carriers at different disease stages were analyzed. Eighty genotype C HBV carriers including 12 hepatitis B e antigen (HBeAg) positive a

Improved tracing of hepatitis B virus tr
Improved tracing of hepatitis B virus transmission chains by phylogenetic analysis based on C region sequences
✍ Hein J. Boot; Jeroen Cremer; Femke D.H. Koedijk; W. Marijn van Ballegooijen; Eli πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 271 KB

## Abstract An effective vaccine is available for the hepatitis B virus (HBV), which is a very contagious human pathogen. The prevalence of chronic HBV infection is very low in the Netherlands (<0.5%), and no universal vaccination is in place. Instead, a program of vaccination for targeted groups a